1
/
of
0
FDA Establishment Inspection Report – Emergent Biosolutions (Janssen Covid Vaccine, Drafted 05/14/2021)
FDA Establishment Inspection Report – Emergent Biosolutions (Janssen Covid Vaccine, Drafted 05/14/2021)
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request Contents: Request the Establishment Inspection Report for the Emergent Biosolutions facility that manufactured drug substance for the Janssen Covid vaccine, originally drafted May 14, 2021
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details